VPS54 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.638000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.606800E-01
Normal-vs-Stage2
4.411600E-01
Normal-vs-Stage3
2.580300E-02
Normal-vs-Stage4
5.233400E-01
Stage1-vs-Stage2
5.158600E-01
Stage1-vs-Stage3
4.731500E-02
Stage1-vs-Stage4
6.477000E-01
Stage2-vs-Stage3
8.819900E-02
Stage2-vs-Stage4
9.771600E-01
Stage3-vs-Stage4
1.903420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.667200E-01
Normal-vs-AfricanAmerican
7.489600E-01
Normal-vs-Asian
2.454000E-01
Caucasian-vs-AfricanAmerican
2.121600E-01
Caucasian-vs-Asian
4.443800E-01
AfricanAmerican-vs-Asian
8.188100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.642200E-01
Normal-vs-Female
6.732200E-01
Male-vs-Female
5.655400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.543600E-01
Normal-vs-Age(41-60Yrs)
7.030200E-01
Normal-vs-Age(61-80Yrs)
5.266400E-01
Normal-vs-Age(81-100Yrs)
3.516000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.771000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.713200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.970200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.470760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.788240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.758600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.068400E-01
Normal-vs-Daily Drinker
2.446600E-01
Normal-vs-Weekly Drinker
1.904800E-01
Normal-vs-Occasional Drinker
9.774400E-01
Normal-vs-Social Drinker
8.036600E-01
Non Drinker-vs-Daily Drinker
6.533400E-01
Non Drinker-vs-Weekly Drinker
4.724600E-01
Non Drinker-vs-Occasional Drinker
3.281600E-01
Non Drinker-vs-Social Drinker
1.597020E-01
Daily Drinker-vs-Weekly Drinker
7.641000E-01
Daily Drinker-vs-Occasional Drinker
2.425400E-01
Daily Drinker-vs-Social Drinker
9.911600E-02
Weekly Drinker-vs-Occasional Drinker
1.941600E-01
Weekly Drinker-vs-Social Drinker
7.861600E-02
Occasional Drinker-vs-Social Drinker
8.470400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.153960E-01
Normal-vs-Grade 2
5.155000E-03
Normal-vs-Grade 3
7.059800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.177000E-01
Grade 1-vs-Grade 3
7.621200E-01
Grade 1-vs-Grade 4
1.153960E-01
Grade 2-vs-Grade 3
1.490410E-01
Grade 2-vs-Grade 4
5.155000E-03
Grade 3-vs-Grade 4
7.059800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.553570E-01
Normal-vs-NonDiabetic
5.803000E-01
Diabetic-vs-NonDiabetic
9.550300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.153800E-01
Normal-vs-NoPancreatitis
4.823600E-01
Pancreatitis-vs-NoPancreatitis
8.374600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.096000E-01
Normal-vs-N1
4.344200E-01
N0-vs-N1
3.566200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.226200E-01
Normal-vs-TP53-NonMutant
9.374400E-01
TP53-Mutant-vs-TP53-NonMutant
2.892000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
